My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 134

    1.

    Flt3-ligand treatment prevents diabetes in NOD mice.

    Chilton PM, Rezzoug F, Fugier-Vivier I, Weeter LA, Xu H, Huang Y, Ray MB, Ildstad ST.

    Diabetes. 2004 Aug;53(8):1995-2002.PMID: 15277378 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice.

    Li H, Kaufman CL, Boggs SS, Johnson PC, Patrene KD, Ildstad ST.

    J Immunol. 1996 Jan 1;156(1):380-8.PMID: 8598488 [PubMed - indexed for MEDLINE]Related articles

    3.

    Increased generation of dendritic cells from myeloid progenitors in autoimmune-prone nonobese diabetic mice.

    Steptoe RJ, Ritchie JM, Harrison LC.

    J Immunol. 2002 May 15;168(10):5032-41.PMID: 11994455 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    A substantial level of donor hematopoietic chimerism is required to protect donor-specific islet grafts in diabetic NOD mice.

    Guo Z, Wu T, Sozen H, Pan Y, Heuss N, Kalscheuer H, Sutherland DE, Blazar BR, Hering BJ.

    Transplantation. 2003 Apr 15;75(7):909-15.PMID: 12698073 [PubMed - indexed for MEDLINE]Related articles

    5.

    Preconditioning of NOD mice with anti-CD8 mAb and costimulatory blockade enhances chimerism and tolerance and prevents diabetes, while depletion of alpha beta-TCR+ and CD4+ cells negates the effect.

    Ildstad ST, Chilton PM, Xu H, Domenick MA, Ray MB.

    Blood. 2005 Mar 15;105(6):2577-84. Epub 2004 Oct 21.PMID: 15498851 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets.

    Naumov YN, Bahjat KS, Gausling R, Abraham R, Exley MA, Koezuka Y, Balk SB, Strominger JL, Clare-Salzer M, Wilson SB.

    Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13838-43. Epub 2001 Nov 13.PMID: 11707602 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice.

    Chan J, Clements W, Field J, Nasa Z, Lock P, Yap F, Toh BH, Alderuccio F.

    J Gene Med. 2006 Nov;8(11):1281-90.PMID: 16989008 [PubMed - indexed for MEDLINE]Related articles

    8.

    Development of insulin-dependent diabetes mellitus in [(NOD + BALB/c) --> NOD] mixed allogeneic bone marrow chimeras.

    Takao F, Yasumizu R, Than S, Ohnishi-Inoue Y, Sigiura K, Inaba M, Ikehara S.

    Immunobiology. 1995 Nov;194(4-5):376-89.PMID: 8749231 [PubMed - indexed for MEDLINE]Related articles

    9.

    Mixed hematopoietic chimerism allows cure of autoimmune diabetes through allogeneic tolerance and reversal of autoimmunity.

    Nikolic B, Takeuchi Y, Leykin I, Fudaba Y, Smith RN, Sykes M.

    Diabetes. 2004 Feb;53(2):376-83.PMID: 14747288 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Hematopoietic mixed chimerism derived from allogeneic embryonic stem cells prevents autoimmune diabetes mellitus in NOD mice.

    Verda L, Kim DA, Ikehara S, Statkute L, Bronesky D, Petrenko Y, Oyama Y, He X, Link C, Vahanian NN, Burt RK.

    Stem Cells. 2008 Feb;26(2):381-6. Epub 2007 Nov 1.PMID: 17975228 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Prevention of diabetes in nonobese diabetic mice by nonmyeloablative allogeneic bone marrow transplantation.

    Elkin G, Prigozhina TB, Slavin S.

    Exp Hematol. 2004 Jun;32(6):579-84.PMID: 15183899 [PubMed - indexed for MEDLINE]Related articles

    12.

    Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation.

    Ikehara S, Ohtsuki H, Good RA, Asamoto H, Nakamura T, Sekita K, Muso E, Tochino Y, Ida T, Kuzuya H, et al.

    Proc Natl Acad Sci U S A. 1985 Nov;82(22):7743-7.PMID: 3906651 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Low levels of allogeneic but not syngeneic hematopoietic chimerism reverse autoimmune insulitis in prediabetic NOD mice.

    Kaminitz A, Mizrahi K, Yaniv I, Farkas DL, Stein J, Askenasy N.

    J Autoimmun. 2009 Sep;33(2):83-91. Epub 2009 Jul 24.PMID: 19632089 [PubMed - indexed for MEDLINE]Related articles

    14.

    Analyses of development of insulitogenic T lymphocytes in NOD mice by transplantation of bone marrow, thymus, and pancreas.

    Ida T, Yasumizu R, Ohnishi Y, Honxue F, Oyaizu N, Than S, Sugiura K, Inaba MM, Kuzuya H, Makino S, et al.

    Transplantation. 1990 May;49(5):976-82.PMID: 2186525 [PubMed - indexed for MEDLINE]Related articles

    15.

    The effect of bone marrow and thymus chimerism between non-obese diabetic (NOD) and NOD-E transgenic mice, on the expression and prevention of diabetes.

    Parish NM, Chandler P, Quartey-Papafio R, Simpson E, Cooke A.

    Eur J Immunol. 1993 Oct;23(10):2667-75.PMID: 8405065 [PubMed - indexed for MEDLINE]Related articles

    16.

    Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.

    Tarbell KV, Petit L, Zuo X, Toy P, Luo X, Mqadmi A, Yang H, Suthanthiran M, Mojsov S, Steinman RM.

    J Exp Med. 2007 Jan 22;204(1):191-201. Epub 2007 Jan 8.PMID: 17210729 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Protection against autoimmune diabetes in mixed bone marrow chimeras: mechanisms involved.

    Mathieu C, Casteels K, Bouillon R, Waer M.

    J Immunol. 1997 Feb 1;158(3):1453-7.PMID: 9013991 [PubMed - indexed for MEDLINE]Related articles

    18.

    Distinct characteristics and features of allogeneic chimerism in the NOD mouse model of autoimmune diabetes.

    Zorina TD, Subbotin VM, Bertera S, Alexander AM, Haluszczak C, Styche AJ, Trucco M.

    Cell Transplant. 2002;11(2):113-23.PMID: 12099635 [PubMed - indexed for MEDLINE]Related articles

    19.

    Donor CD8+ T cells facilitate induction of chimerism and tolerance without GVHD in autoimmune NOD mice conditioned with anti-CD3 mAb.

    Liang Y, Huang T, Zhang C, Todorov I, Atkinson M, Kandeel F, Forman S, Zeng D.

    Blood. 2005 Mar 1;105(5):2180-8. Epub 2004 Sep 16.PMID: 15374883 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes.

    Chen YG, Choisy-Rossi CM, Holl TM, Chapman HD, Besra GS, Porcelli SA, Shaffer DJ, Roopenian D, Wilson SB, Serreze DV.

    J Immunol. 2005 Feb 1;174(3):1196-204.PMID: 15661873 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity